Article
Utility of germline multi-gene panel testing in patients with endometrial cancer.
Gynecologic oncology - 1 Jun 2022
Karpel Hannah C, Chern Jing-Yi, Smith J Maria, Smith A Julia, Pothuri Bhavana
Abstract excerpt
OBJECTIVES: Patients with germline mutations in mismatch repair genes (MLH1, MSH2, MSH6, PMS2) associated with Lynch syndrome (LS) have an increased lifetime risk of endometrial cancer (EC). Multi-gene panel testing (MGPT) is a recent hereditary cancer risk tool enabling next-generation sequencing of numerous genes in parallel. We determined the prevalence of actionable cancer predisposition gene mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
